Latest filing published 24 Dec 2014 for Tobira Therapeutics, Inc., €8,377.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert A. Kierlin: trading record in brief
Robert A. Kierlin is a declared insider at 2 companies; the most frequent names are Fastenal Co and Tobira Therapeutics, Inc. The record holds 83 filings, for trades running from 9 November 2005 to 28 October 2014.
Both buying and selling appear: 3 purchases worth €6.2M, against 58 sales worth €163.6M. Sales outweigh purchases by €157.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2014 to date brings 2 purchases and 7 sales.
The median purchase comes to €2.2M.
Most recently, on 24 December 2014, the filings show an open-market sale worth €8,377 in Tobira Therapeutics, Inc. The last purchase on record was published on 17 April 2014, which is 4,588 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert A. Kierlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.06Common Stock, par value $0.001 per shareSEC:0000905718-14-000837:0
- 100,000 shares@ US$1.10Common Stock, par value $0.001 per shareSEC:0000905718-14-000837:1
- 18,748 shares@ US$1.08Common Stock, par value $0.001 per shareSEC:0000905718-14-000837:2
- 941,252 shares@ US$1.10Common Stock, par value $0.001 per shareSEC:0000905718-14-000837:3
- 60,000 shares@ US$49.17Common StockSEC:0001179110-14-009906:0
- 30,000 shares@ US$48.65Common StockSEC:0001179110-14-007937:0
- 28,100 shares0Common StockSEC:0001179110-14-007937:1
- 10,275 shares0Common StockSEC:0001179110-14-007096:0
- 70,000 shares@ US$49.77Common StockSEC:0001179110-14-007096:1
- 575,000 shares@ US$6.00Common Stock, par value $0.001 per shareSEC:0000905718-14-000152:0Canonical exit: 15 Jul 2014 (T+90)
- 400,000 shares@ US$5.00Common Stock, par value $0.001 per shareSEC:0001140361-14-005055:0Canonical exit: 6 May 2014 (T+90)
- 11,000 shares0Common StockSEC:0001179110-14-001618:0
- 200,000 shares@ US$49.16Common StockSEC:0001179110-13-016234:0
- 9,570 shares0Common StockSEC:0001179110-13-015487:0
- 18,000 shares0Common StockSEC:0001179110-13-015487:1
- 18,930 shares0Common StockSEC:0001179110-13-015487:2
- 1,420 shares0Common StockSEC:0001179110-13-015487:3
- 100,000 shares@ US$47.77Common StockSEC:0001179110-13-015487:4
- 201,785 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034590:0
- 100,050 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034590:1
- 199,050 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034590:2
- 1,392,875 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034590:3
- 634,718 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034590:4
- 100,000 shares@ US$41.71Common StockSEC:0001179110-12-017152:0
- 107,500 shares0Common StockSEC:0001179110-12-017152:1
25 of 82 declarations
